Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

China Has Been Practicing for an Invasion Under the Guise of a Military Exercise

As tensions continue to escalate between Washington and Beijing,…
Read more

China Threatens to Nuke Japan Over Taiwan in Video Played on CCP-Sanctioned Channel

The Chinese Communist Party aired a video in which it warned…
Read more

Cuba Protests: 5,000 Arrested, Police Target Religious Leaders

Independent media confirmed the arrests of at least 5,000…
Read more